EMBLEM™ MRI S-ICD System

Subcutaneous Implantable Defibrillator

Pre-Clinical Data

Explore the articles below for pre-clinical data evaluating the use of mCRM™ Modular CRM Systems in animal subjects. NOTE: You may need a subscription to read the full articles.

Results at a Glance

100%
Chronic mCRM Communication Success Rate1
0.72V
@ 0.5ms - Acceptable Pacing Capture Thresholds at 90 Days2
 

Pre-Clinical Articles

Device-device communication stability of leadless anti-tachycardia pacemaker and subcutaneous implantable cardioverter defibrillator over 18 months
Tjong, F.V.Y., et al. | Heart Rhythm | 2020
Read Article

Acute and chronic retrieval of a leadless cardiac pacemaker from the right ventricle
Tjong, F.V.Y., et al. | Heart Rhythm | 2019
Read Article

The modular cardiac rhythm management system: the EMPOWER Leadless Pacemaker and the EMBLEM subcutaneous ICD
Tjong, F.V.Y., et al. | Herzschr Elektrophys | 2018
Read Article

Device orientation of a leadless pacemaker and subcutaneous implantable cardioverter-defibrillator in canine and human subjects and the effect on intrabody communication 
Quast, A.B.E., et al. | EP Europace | 2018
Read Article

Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator
Tjong, F.V.Y., et al. | JACC Clin Electrophysiol | 2017
Read Article

Find a Site

Study Site Locator

The MODULAR ATP Clinical Study will enroll patients at sites in North America and Europe. If you have a patient who may be a candidate, view the active site list to find contact information for a study physician near you.
 
mCRM Technology

mCRM Technology

Discover how a modular approach to ICD therapy may reduce the risks of TV leads while providing pacing if needed.

Button
MODULAR ATP Study

MODULAR ATP Study

Learn about the MODULAR ATP Clinical Study design, primary effectiveness and safety endpoints, timelines and more.

Button
Study Eligibility

Study Eligibility

Explore patient inclusion and exclusion criteria and find resources to help you refer study candidates.

Button
 

References

1. Tjong FV, Knops R, Koop B, Soltis B, Brisben AJ, Swackhamer B, Burke MC. Device-device communication stability of leadless anti-tachycardia pacemaker and subcutaneous implantable cardioverter defibrillator over 18 months. Heart Rhythm 2020;17(5 Supplement):s11.https://doi.org/10.1016/j.hrthm.2020.04.005

2. Tjong FVY, Brouwer TF, Koop B, Soltis B, Shuros A, Schmidt B, Swackhamer B, Quast AEB, Wilde AAM, Burke MC, Knops RE. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator. JACC Clin Electrophysiol. 2017 Dec 26;3(13):1487-1498. doi: 10.1016/j.jacep.2017.04.002. Epub 2017 May 31.

Top